AstraZeneca on Thursday said it could face a fine of up to $4.5 million in China over suspected unpaid import taxes, raising ...

AstraZeneca investors will look past another strong set of quarterly results on Thursday to focus on the main issue ...

How an agreement set up by the Tories and lauded by Labour fell victim to cost-cutting and UK curbs on drugs expenditure ...

AstraZeneca’s planned vaccine hub for Liverpool is off the table - business editor Karl Matchett and Whitehall editor Kate ...

Indicates growing incidence of cancer among Indian population; five out of top 20 new brand launches are cancer drugs ...

Shares of AstraZeneca Pharma India Ltd closed at ₹7,450 on the BSE, down 1.29% ahead of the earnings announcement.

AstraZeneca could face a fine of up to $4.5 million in China over suspected unpaid taxes related to the import of two of its ...

Earnings per share excluding some items surged to $2.09, Astra said Thursday, higher than the $2.04 estimated by analysts ...

The pharmaceuticals major was boosted by high demand for its key drugs that offset a slight sales drop in China.

Strength in the pharmaceutical major’s oncology business offset weak China sales, but the company has warned of a potential ...

As per the reported property consultants, the company has issued a global mandate for selecting candidates for the said land ...

AstraZeneca has cancelled a multi-million pound investment in a vaccine plant in Merseyside because the government failed to ...